Literature DB >> 3808130

[Central pontine myelinolysis].

P Berlit.   

Abstract

A review is given on symptoms, etiology, pathogenesis and prognosis of central pontine myelinolysis (CPM). Since 1959, 315 cases of CPM have been reported in world literature, 41 per cent of the patients described developed their neurological symptoms in the course of chronic alcoholism. In about 32 per cent CPM was connected with electrolyte disturbance, especially hypo- or hypernatremia. Beside the complications of alcoholism, accompanying diseases were malignancies (9%) infections of the lung (10%) and diseases of the central nervous system (7%). Current theories about etiology and pathogenesis of CPM are reviewed with special reference to the syndrome of inappropriate secretion of the antidiuretic hormone (IADH). Own experiences with clinical diagnosis of CPM are reported. Seven patients with neurological symptoms in hyponatremia have been seen prospectively during one year. In three cases clinically, in one patient neuropathologically the diagnosis of CPM was made.

Entities:  

Mesh:

Year:  1986        PMID: 3808130

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  4 in total

Review 1.  [Central pontine myelosis. Morphology and forensic importance].

Authors:  H Bratzke; K Neumann
Journal:  Z Rechtsmed       Date:  1989

2.  [Central pontine myelinolysis following severe hyponatremia].

Authors:  J A Schmidt; A Krause; C O Feddersen; F V Kohl; G Mariss; A Lütcke; P von Wichert
Journal:  Klin Wochenschr       Date:  1990-02-01

3.  Central pontine myelinolysis associated with low potassium levels in alcoholism.

Authors:  M Bähr; N Sommer; D Petersen; H Wiethölter; J Dichgans
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

4.  Central Pontine Myelinosis and Osmotic Demyelination Syndrome.

Authors:  Johann Lambeck; Maren Hieber; Andrea Dreßing; Wolf-Dirk Niesen
Journal:  Dtsch Arztebl Int       Date:  2019-09-02       Impact factor: 5.594

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.